So Medicago, a clinical-stage biopharmaceutical company located in Quebec, Canada, is harnessing a plant-based transient expression process to produce pharmaceutical-grade proteins in a matter of ...
Nicotiana genus plants were chosen because they grow ... the officials said. Medicago signed an agreement to sell 76 million doses of the vaccine to the Canadian government.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback